VIVECA BIOMED LIMITED

What VIVECA BIOMED LIMITED does

Viveca Biomed Limited is a UK-based medical device company, founded in 2018, that manufactures and distributes Contrelle Activgard, a biocompatible foam bladder support designed as a non-invasive management option for women with stress urinary incontinence (SUI). The product is regulated as a Class IIa medical device under CE marking and operates in the underserved, conservative-treatment segment of the female pelvic-health market, where the addressable population in the UK alone is estimated at approximately 5 million women, with comparable demand in continental Europe (around 20 million) and North America (around 20 million).

Commercially, Viveca sells through a multi-channel go-to-market model that combines pharmacy distribution, direct-to-consumer (D2C) channels, and — following recent NHS prescription approval — public reimbursement in the UK. The device is single-use and low unit-cost, generating revenue through volume rather than enterprise contracts, and the company has scaled distribution to 20+ countries with a cumulative installed base of approximately 6 million devices used globally. Manufacturing is conducted at the company's facility in Ashington, Northumberland, localizing production within the UK.

Operationally, Viveca is a small, growing UK team led by CEO Andrew Tasker. The capital base to date has been grant-based — including ERDF/North of Tyne Rural Business Growth Service funding — rather than institutional venture capital. This is consistent with the company's positioning as a clinically validated, distribution-led medical-device business rather than a venture-backed R&D platform; growth is being driven primarily through channel expansion (NHS, additional geographies) and brand/cumulative-use trust rather than novel technology cycles.

Name

VIVECA BIOMED LIMITED

Legal name

Viveca Biomed Limited

Website

https://vivecabiomed.co.uk

Company type

Private

Founded year

2018

Operating status

Operating

Short description

Viveca Biomed Limited is a UK medical device company that manufactures and distributes Contrelle Activgard, a biocompatible foam bladder support for female stress urinary incontinence, sold across 20+ countries via pharmacy, D2C, and NHS channels.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)

akta.pro secondary industries

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG), Medical & Hygiene Disposables (Underpads, Disposable Washcloths, Bed Bath Products) (CRADALAK)

Keywords

• Medical devices
• Female incontinence
• Bladder support
• Women's healthcare
• Stress urinary incontinence

Headquarters

HQ city

Ashington

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of Contrelle Activgard bladder support devices to healthcare providers, pharmacies, and directly to consumers. Products sold in sizing kits, 5-packs, and 30-packs. Revenue generated from NHS prescriptions and consumer purchases.
2. Prescription/Clinical Sales: Revenue from NHS prescription sales and healthcare professional channel. The company has been approved for prescription use.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Viveca Biomed Limited designs, manufactures, and distributes Contrelle Activgard, a Class IIa medical device made from a proprietary biocompatible foam that supports the bladder neck to treat female stress urinary incontinence. The company sells a sizing kit and refill packs (5-pack and 30-pack) in three sizes through its own consumer website, NHS prescriptions, pharmacies, and a global distribution partner network.

Product overview

Viveca Biomed Limited is a specialist female healthcare business and manufacturer of Contrelle Activgard, a Class IIa medical device for treating female stress urinary incontinence. The product portfolio consists of the Contrelle Sizing Kit (containing all three sizes: Small, Medium, Large), which enables women to find the most effective fit, followed by 5-packs and 30-packs in each size for regular ongoing use. All products are manufactured in-house at the company's bespoke facility in Ashington, Northumberland.

Differentiator

Problem solved

Functional benefit

Brands

• Contrelle Activgard: A comfortable, discreet, easy to use bladder support designed to reduce or stop bladder leaks caused by Stress Urinary Incontinence (SUI). A soft foam device that gently supports the bladder neck and is manufactured by Viveca Biomed Limited.

Products and services

• Contrelle Activgard A Class IIa medical device bladder support made from a proprietary biocompatible foam for treating female stress urinary incontinence and mixed incontinence where stress is prevalent. It gently supports the bladder neck, improves bladder angle, applies gentle pressure on the urethra, and stops bladder mobility. Supported by seven clinical trials with statistical significance and 12-month data showing 94% symptom improvement.
• Contrelle Sizing Kit An initial fitting kit containing all three Contrelle Activgard sizes (Size 1 Small, Size 2 Medium, Size 3 Large) to help women identify the most effective and comfortable fit before purchasing refill packs.

Quantifiable outcome

• 94% of women report improvement in symptoms at 12 months
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Smart CarbonminorOthersSmart Carbon worked with Viveca Biomed to determine scope 1 and 2 emissions, alongside a subset of relevant scope 3 emissions for their carbon footprint report.
• ENTE Certificazione Macchine SRL (ECM)coreOthersNotified Body (No. 1282) based in Italy that approved Viveca Biomed's manufacturing quality assurance system. Conforms with Medical Device Directive 93/42/EEC.
• CS Life Sciences Europe LtdcoreOthersAppointed to act for Viveca Biomed Ltd within the European Union. Located at 3 Inns Quay, Dublin 7, Ireland.
• Global Distribution PartnerscoreChannel Partner/ Reseller/ DistributorWorks with distribution partners in over 20 countries. Partners benefit from consistent point of contact, shared category expertise and key opinion leaders, marketing advice and shareable assets, and market learnings.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Boston Scientific: Global medical device leader with the INTERSTIM sacral neuromodulation system for overactive bladder and incontinence. Comparable as a broad incumbent in incontinence treatments, including the same end-patient indications, but distributed through specialty urology channels.
• Coloplast: Global leader in continence care, ostomy, and wound care products. Directly comparable as a medical device manufacturer addressing incontinence/urological supply needs, though Coloplast's portfolio is far broader and includes catheters, pessaries, and surgical mesh.
• ConvaTec: Major medical products company with a continence care and ostomy franchise. Comparable as an established player in urological/continence supplies serving both hospital and consumer channels, but with a much larger portfolio and global infrastructure.
• Kimberly-Clark (Poise): Owner of the Poise brand, the largest consumer incontinence pad brand in the US and a former direct competitor with the Poise Impressa intravaginal SUI device (now discontinued). Comparable as the dominant consumer-facing continence brand competing for the same end customer.
• Axonics Modulation Technologies: Public medical device company offering sacral neuromodulation implants for urinary and fecal incontinence. Comparable as a competitor targeting the same SUI/urge incontinence patient population, though Axonics focuses on implantable neurostimulation rather than conservative intravaginal devices.
• B. Braun: Global medical device and pharmaceutical company with a continence care and urology portfolio including catheters and irrigation systems. Comparable as a broad incumbent in urological/continence medical devices distributed through healthcare channels worldwide.
• Laborie Medical Technologies: Specialty medical device company focused on urology and pelvic health diagnostics and therapeutics. Comparable as a broader player in pelvic floor and incontinence care, with overlapping end-customer relationships in urogynaecology clinics and NHS channels.
• Hollister Incorporated: Established continence care and ostomy supplier with deep relationships in NHS and international healthcare systems. Comparable as a manufacturer and distributor of urological supplies, though Hollister's range and scale are materially larger than Viveca.

Emerging players

• Atlantic Therapeutics: Developer of INNOVO, a non-invasive pelvic floor stimulation device for stress urinary incontinence. Comparable as a focused SUI device company competing for the same conservative-treatment patient segment, though Atlantic uses external electrical stimulation rather than an intravaginal support.
• Elidah Medical: US-based company marketing Elitone, an external non-invasive pelvic floor stimulation device for female SUI. Comparable as a smaller emerging SUI device competitor targeting the same first-line conservative treatment niche, but with a different modality (external stimulation vs. intravaginal support).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VIVECA BIOMED LIMITED